Showing 151-160 of 2192 results for "".
MS Minute: Update on BTK Inhibitors for Multiple Sclerosis—A New Treatment That Brings New Hope
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/update-on-btk-inhibitors-for-multiple-sclerosis-a-new-treatment-that-brings-new-hope/40007/BTK inhibitors are the first class of medications to slow disability progression in secondary progressive multiple sclerosis without clinical relapses.Congenital Myasthenic Syndrome Treatment
https://practicalneurology.com/diseases-diagnoses/neuromuscular/congenital-myasthenic-syndrome-treatment/31555/Heterogeneity makes diagnosis and treatment challenging.Intracranial Atherosclerotic Disease
https://practicalneurology.com/diseases-diagnoses/stroke/intracranial-atherosclerotic-disease/30143/Neurologists need to be vigilant for this common cause of ischemic stroke, associated with the highest rates of recurrent stroke.Neuro-Oncology Outlook: Advancements in Targeted Molecular Therapy for Low-Grade Gliomas—Challenging the Treatment Paradigm
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neuro-oncology-outlookbradvancements-in-targeted-molecular-therapy-for-low-grade-gliomas-challenging-the-treatment-paradigm/32121/Treatment with the IDH inhibitor vorasidenib increased median progression-free survival and time to next intervention in individuals with grade 2 gliomas under surveillance after surgical resection.Acupuncture for Headache Management: What is the Evidence? Where Do We Go from Here?
https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0309_07-php/30938/Recent research of higher quality than that of the past suggests a possible role for acupuncture in headache care.Are Anti-amyloid Therapies Still Worth Being Developed as Treatments for Alzheimer's Disease?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/are-anti-amyloid-therapies-still-worth-being-developed-as-treatments-for-alzheimers-disease/30832/Despite limited pharmaceutical success thus far, amyloid peptides may yet prove useful in the treatment of Alzheimer's and delay disease progression.Special Report: 2023 Neurology Drug & Device Approvals
https://practicalneurology.com/diseases-diagnoses/imaging-testing/special-report-2023-neurology-drug-device-approvals/32081/A quick reference for the drugs and devices for neurologic conditions that received approval from the Food and Drug Administration last year.Neurologic Complications of Globally Prevalent Infectious Disorders: A Focus on Syphilis, Cysticercosis, and Tuberculosis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/neurologic-complications-of-globally-prevalent-infectious-disorders-a-focus-on-syphilis-cysticercosis-and-tuberculosis/32153/In the presence of CNS infections, neurologists should have a high index of suspicion for syphilis, tuberculosis, or cysticercosis, especially in people from endemic areas and immunocompromised individuals.MS Minute: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/32180/MOGAD, an inflammatory demyelinating disease of the central nervous system, has some overlapping clinical features with NMOSD and MS but is a distinct entity with unique pathologic, clinical, and imaging features.Autologous Umbilical Cord Blood Treatment for Autism: Rationale and Potential Goals of Treatment
https://practicalneurology.com/columns/practice-management/autologous-umbilical-cord-blood-treatment-for-autism-rationale-and-potential-goals-of-treatment/30725/Could autologous umbilical cord blood (AUCB) offer stem cells that could alter functionality of aberrant immune or nervous system cells affected by some environmental factor in patients with negative genetic screening for autism?